David Roman
Stock Analyst at Goldman Sachs
(1.84)
# 3,259
Out of 5,123 analysts
61
Total ratings
34.29%
Success rate
-5.17%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Buy | $49 | $46.20 | +6.06% | 1 | Jan 12, 2026 | |
| HQY HealthEquity | Downgrades: Sell | $89 | $79.22 | +12.35% | 4 | Jan 9, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $22 → $25 | $25.14 | -0.54% | 3 | Dec 15, 2025 | |
| COO The Cooper Companies | Maintains: Sell | $64 → $71 | $80.10 | -11.36% | 2 | Dec 8, 2025 | |
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $102.95 | +7.82% | 2 | Nov 19, 2025 | |
| IRTC iRhythm Holdings | Maintains: Neutral | $180 → $202 | $146.75 | +37.65% | 4 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $94 → $104 | $78.10 | +33.16% | 4 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $25 → $22 | $21.77 | +1.06% | 4 | Oct 31, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $26 → $33 | $13.24 | +149.24% | 3 | Oct 29, 2025 | |
| BLCO Bausch + Lomb | Initiates: Neutral | $16 | $16.41 | -2.50% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $103 | $113.52 | -9.27% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $57 → $64 | $33.32 | +92.08% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $12.57 | +59.11% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $11.29 | +68.29% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $11.99 | +141.97% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $243.15 | +56.28% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $88.73 | +17.21% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $4.73 | +111.42% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $82.31 | -0.38% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $109.08 | +41.18% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $18.94 | +26.72% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $76.98 | -7.77% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $65.03 | -15.42% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $362.42 | +17.82% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $77.64 | +15.92% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $476.32 | +4.97% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $206.51 | +32.68% | 1 | May 30, 2024 |
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $49
Current: $46.20
Upside: +6.06%
HealthEquity
Jan 9, 2026
Downgrades: Sell
Price Target: $89
Current: $79.22
Upside: +12.35%
Kestra Medical Technologies
Dec 15, 2025
Maintains: Neutral
Price Target: $22 → $25
Current: $25.14
Upside: -0.54%
The Cooper Companies
Dec 8, 2025
Maintains: Sell
Price Target: $64 → $71
Current: $80.10
Upside: -11.36%
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $102.95
Upside: +7.82%
iRhythm Holdings
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $146.75
Upside: +37.65%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $94 → $104
Current: $78.10
Upside: +33.16%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $25 → $22
Current: $21.77
Upside: +1.06%
Beta Bionics
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $13.24
Upside: +149.24%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $16.41
Upside: -2.50%
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $113.52
Upside: -9.27%
Oct 1, 2025
Downgrades: Sell
Price Target: $57 → $64
Current: $33.32
Upside: +92.08%
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $12.57
Upside: +59.11%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $11.29
Upside: +68.29%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $11.99
Upside: +141.97%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $243.15
Upside: +56.28%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $88.73
Upside: +17.21%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $4.73
Upside: +111.42%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $82.31
Upside: -0.38%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $109.08
Upside: +41.18%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $18.94
Upside: +26.72%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $76.98
Upside: -7.77%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $65.03
Upside: -15.42%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $362.42
Upside: +17.82%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $77.64
Upside: +15.92%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $476.32
Upside: +4.97%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $206.51
Upside: +32.68%